1
|
Lee JJ and Chu E: Update on clinical data
combining capecitabine with targeted agents in newly diagnosed
colorectal cancer. Clin Colorectal Cancer. 7:S16–S20. 2007.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Giovannucci E, Rimm EB, Ascherio A, et al:
Alcohol, low-methionine - low-folate diets, and risk of colon
cancer in men. J Natl Cancer Inst. 87:265–273. 1995. View Article : Google Scholar : PubMed/NCBI
|
3
|
Linhart HG, Lin H, Yamada Y, et al: Dnmt3b
promotes tumorigenesis in vivo by gene-specific de novo methylation
and transcriptional silencing. Genes Dev. 21:3110–3122. 2007.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Jones PA and Laird PW: Cancer epigenetics
comes of age. Nat Genet. 21:163–167. 1999. View Article : Google Scholar : PubMed/NCBI
|
5
|
Baylin SB and Herman JG: DNA
hypermethylation in tumorigenesis: epigenetics joins genetics.
Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
6
|
Esteller M, Corn PG, Baylin SB and Herman
JG: A gene hypermethylation profile of human cancer. Cancer Res.
61:3225–3229. 2001.PubMed/NCBI
|
7
|
Bachman KE, Rountree MR and Baylin SB:
Dnmt3a and Dnmt3b are transcriptional repressors that exhibit
unique localization properties to heterochromatin. J Biol Chem.
276:32282–32287. 2001. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bao Q, He B, Pan Y, et al: Genetic
variation in the promoter of DNMT3B is associated with the risk of
colorectal cancer. Int J Colorectal Dis. 26:1107–1112. 2011.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Jones JS, Amos CI, Pande M, et al: DNMT3b
polymorphism and hereditary nonpolyposis colorectal cancer age of
onset. Cancer Epidemiol Biomarkers Prev. 15:886–891. 2006.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Fan H, Zhang F, Hu J, et al: Promoter
polymorphisms of DNMT3B and the risk of colorectal cancer in
Chinese: a case-control study. J Exp Clin Cancer Res. 27:242008.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Reeves SG, Mossman D, Meldrum CJ, et al:
The −149C>T SNP within the DeltaDNMT3B gene, is not associated
with early disease onset in hereditary non-polyposis colorectal
cancer. Cancer Lett. 265:39–44. 2008.
|
12
|
de Vogel S, Wouters KA, Gottschalk RW, et
al: Genetic variants of methyl metabolizing enzymes and epigenetic
regulators: associations with promoter CpG island hypermethylation
in colorectal cancer. Cancer Epidemiol Biomarkers Prev.
18:3086–3096. 2009.PubMed/NCBI
|
13
|
Iacopetta B, Heyworth J, Girschik J, et
al: The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer
different risks for right- and left-sided colorectal cancer. Int J
Cancer. 125:84–90. 2009. View Article : Google Scholar
|
14
|
Karpinski P, Myszka A, Ramsey D, et al:
Polymorphisms in methyl-group metabolism genes and risk of sporadic
colorectal cancer with relation to the CpG island methylator
phenotype. Cancer Epidemiol. 34:338–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Skoog T, van’t Hooft FM, Kallin B, et al:
A common functional polymorphism (C-->A substitution at position
−863) in the promoter region of the tumor necrosis factor-alpha
(TNF-alpha) gene associated with reduced circulating levels of
TNF-alpha. Hum Mol Genet. 8:1443–1449. 1999.
|
16
|
Momparler RL and Bovenzi V: DNA
methylation and cancer. J Cell Physiol. 183:145–154. 2000.
View Article : Google Scholar
|
17
|
Shen H, Wang L, Spitz MR, et al: A novel
polymorphism in human cytosine DNA-methyltransferase-3B promoter is
associated with an increased risk of lung cancer. Cancer Res.
62:4992–4995. 2002.PubMed/NCBI
|
18
|
Montgomery KG, Liu MC, Eccles DM and
Campbell IG: The DNMT3B C-->T promoter polymorphism and risk of
breast cancer in a British population: a case-control study. Breast
Cancer Res. 6:R390–R394. 2004.
|
19
|
Hong YS, Lee HJ, You CH, et al: DNMT3b
39179GT polymorphism and the risk of adenocarcinoma of the colon in
Koreans. Biochem Genet. 45:155–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Singal R, Das PM, Manoharan M, et al:
Polymorphisms in the DNA methyltransferase 3b gene and prostate
cancer risk. Oncol Rep. 14:569–573. 2005.PubMed/NCBI
|
21
|
Aung PP, Matsumura S, Kuraoka K, et al: No
evidence of correlation between the single nucleotide polymorphism
of DNMT3B promoter and gastric cancer risk in a Japanese
population. Oncol Rep. 14:1151–1154. 2005.PubMed/NCBI
|